Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2012

01.01.2012 | Retinal Disorders

Association between photoreceptor integrity and visual outcome in diabetic macular edema

verfasst von: Hyun Jin Shin, Seung Hyen Lee, Hyewon Chung, Hyung Chan Kim

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the correlation between foveal photoreceptor integrity and final visual acuity (VA) after treatment of eyes with diabetic macular edema (DME), and to determine the visual prognostic factors.

Methods

We retrospectively studied 61 eyes of 52 patients with DME who were treated successfully with intravitreal triamcinolone injection (IVTA). Using spectral domain optical coherence tomography (SD-OCT), the eyes were categorized into three groups at the final visit according to restoration of the photoreceptor inner and outer segment junction (IS/OS) and the external limiting membrane (ELM): (1) the A group, with a completely visible IS/OS and ELM, (2) the B group, with a disrupted IS/OS and intact ELM, and (3) the C group, with a disrupted or loss of the IS/OS and ELM. Disrupted IS/OS length (DIL), disrupted ELM length (DEL), and mean disrupted IS/OS and ELM length (DIEL) were measured at the initial and final visits. Foveal thickness (FT), macular center thickness (MCT), and outer nuclear layer (ONL) thickness were also measured at the initial and final visits. Multivariate analysis testing was performed over the measured SD OCT variables.

Results

Final VA was closely associated with IS/OS integrity at the final visit; final VA (logMAR) in the A group (0.21 ± 0.14; 31 eyes) or B group (0.31 ± 0.21; 15 eyes) was significantly better than that in the C group (0.45 ± 0.33; 15 eyes) (p < 0.001). Shorter DIL, DEL, and DIEL at the final visit were associated with better final VA. Multivariate analysis showed that DIEL (r = 0.564) have the greatest correlation coefficient with final VA compared to DIL (r = 0.561) and DEL (r = 0.540). Better VA, preservation of the IS/OS and ELM at the initial visit were associated with intact photoreceptor integrity after resolution of DME. However, MCT, FT, and ONL thickness had no significant correlation with photoreceptor integrity.

Conclusion

IS/OS and ELM are useful hallmarks for use in evaluation of foveal photoreceptor layer integrity, and are closely associated with final VA in DME. Pretreatment VA and photoreceptor status can predict potential restoration of photoreceptor integrity and subsequent visual recovery in DME.
Literatur
1.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Linton KL (1992) Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 99:58–62PubMed Klein R, Klein BE, Moss SE, Linton KL (1992) Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 99:58–62PubMed
2.
Zurück zum Zitat Brensick GH (1983) A critical review highlighting diffuse macular edema. Ophthalmology 90:1301–1317 Brensick GH (1983) A critical review highlighting diffuse macular edema. Ophthalmology 90:1301–1317
3.
Zurück zum Zitat Mcdonald HR, Schatz H (1985) Grid photocoagulation for diffuse macular edema. Retina 5:65–72PubMedCrossRef Mcdonald HR, Schatz H (1985) Grid photocoagulation for diffuse macular edema. Retina 5:65–72PubMedCrossRef
4.
Zurück zum Zitat Olk RJ (1986) Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93:938–950PubMed Olk RJ (1986) Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93:938–950PubMed
5.
Zurück zum Zitat Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753–759PubMed Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753–759PubMed
6.
Zurück zum Zitat Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405–413PubMed Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405–413PubMed
7.
Zurück zum Zitat Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258–260PubMed Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258–260PubMed
8.
Zurück zum Zitat Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999–1005PubMedCrossRef Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999–1005PubMedCrossRef
9.
Zurück zum Zitat Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME, Pan-American Collaborative Retina Study Group (2007) Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114:743–750PubMedCrossRef Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME, Pan-American Collaborative Retina Study Group (2007) Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114:743–750PubMedCrossRef
10.
Zurück zum Zitat Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927PubMedCrossRef Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927PubMedCrossRef
11.
Zurück zum Zitat Avitabile T, Longo A, Reibaldi A (2005) Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoids macular edema. Am J Ophthalmol 140:695–702PubMedCrossRef Avitabile T, Longo A, Reibaldi A (2005) Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoids macular edema. Am J Ophthalmol 140:695–702PubMedCrossRef
12.
Zurück zum Zitat Sakamoto A, Nishijima K, Kita M, Oh H, Tsujikawa A, Yoshimura N (2009) Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 247:1325–1330PubMedCrossRef Sakamoto A, Nishijima K, Kita M, Oh H, Tsujikawa A, Yoshimura N (2009) Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 247:1325–1330PubMedCrossRef
13.
Zurück zum Zitat Hangai M, Ojima Y, Yoshida A, Yasuno Y, Makita S, Yatagai T, Yoshimura N (2007) Improved visualization of foveal pathologies using Fourier-domain optical coherence tomography. Nippon Ganka Gakkai Zasshi 111:509–517PubMed Hangai M, Ojima Y, Yoshida A, Yasuno Y, Makita S, Yatagai T, Yoshimura N (2007) Improved visualization of foveal pathologies using Fourier-domain optical coherence tomography. Nippon Ganka Gakkai Zasshi 111:509–517PubMed
14.
Zurück zum Zitat Hangai M, Ojima Y, Gotoh N, Inoue R, Yasuno Y, Makita S, Yamanari M, Yatagai T, Kita M, Yoshimura N (2007) Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 114:763–773PubMedCrossRef Hangai M, Ojima Y, Gotoh N, Inoue R, Yasuno Y, Makita S, Yamanari M, Yatagai T, Kita M, Yoshimura N (2007) Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 114:763–773PubMedCrossRef
15.
Zurück zum Zitat Sakamoto A, Tsujikawa A, Ota M, Yamaike N, Kotera Y, Miyamoto K, Kita M, Yoshimura N (2009) Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion. Clin Exp Ophthalmol 37:208–216CrossRef Sakamoto A, Tsujikawa A, Ota M, Yamaike N, Kotera Y, Miyamoto K, Kita M, Yoshimura N (2009) Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion. Clin Exp Ophthalmol 37:208–216CrossRef
16.
Zurück zum Zitat Ota M, Tsujikawa A, Murakami T, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Yoshimura N (2007) Association between integrity of foveal photoreceptor layer and visual acuity in branched retinal vein occlusion. Br J Ophthalmol 91:1644–1649PubMedCrossRef Ota M, Tsujikawa A, Murakami T, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Yoshimura N (2007) Association between integrity of foveal photoreceptor layer and visual acuity in branched retinal vein occlusion. Br J Ophthalmol 91:1644–1649PubMedCrossRef
17.
Zurück zum Zitat Ota M, Tsujikawa A, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Kotera Y, Yoshimura N (2008) Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 28:1502–1508PubMedCrossRef Ota M, Tsujikawa A, Kita M, Miyamoto K, Sakamoto A, Yamaike N, Kotera Y, Yoshimura N (2008) Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 28:1502–1508PubMedCrossRef
18.
Zurück zum Zitat Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N (2009) Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 148:83–89PubMedCrossRef Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N (2009) Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 148:83–89PubMedCrossRef
19.
Zurück zum Zitat Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626PubMedCrossRef Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626PubMedCrossRef
20.
Zurück zum Zitat Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99PubMedCrossRef Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99PubMedCrossRef
21.
Zurück zum Zitat Eandi DM, Chung JE, Cardillo-Piccolino F, Spaide RF (2005) Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 25:417–421PubMedCrossRef Eandi DM, Chung JE, Cardillo-Piccolino F, Spaide RF (2005) Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 25:417–421PubMedCrossRef
22.
Zurück zum Zitat Yamaike N, Tsujikawa A, Ota M, Sakamoto A, Kotera Y, Kita M, Miyamoto K, Yoshimura N, Hangai M (2008) Three-dimensional imaging of cystoids macular edema in retinal vein occlusion. Ophthalmology 115:355–362PubMedCrossRef Yamaike N, Tsujikawa A, Ota M, Sakamoto A, Kotera Y, Kita M, Miyamoto K, Yoshimura N, Hangai M (2008) Three-dimensional imaging of cystoids macular edema in retinal vein occlusion. Ophthalmology 115:355–362PubMedCrossRef
23.
Zurück zum Zitat Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y (2010) The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol 150:27–32PubMedCrossRef Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y (2010) The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol 150:27–32PubMedCrossRef
24.
Zurück zum Zitat Wakabayashi T, Oshima Y, Fujimoto H, Murakami Y, Sakaguchi H, Kusaka S, Tano Y (2009) Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology 116:519–528PubMedCrossRef Wakabayashi T, Oshima Y, Fujimoto H, Murakami Y, Sakaguchi H, Kusaka S, Tano Y (2009) Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology 116:519–528PubMedCrossRef
25.
Zurück zum Zitat Maheshwary AS, Oster SF, Ritchie M, Yuson RM, Cheng L, Mojana F, Freeman WR (2010) The association between percent disruption of the photoreceptor inner segment–outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol 150:63–67PubMedCrossRef Maheshwary AS, Oster SF, Ritchie M, Yuson RM, Cheng L, Mojana F, Freeman WR (2010) The association between percent disruption of the photoreceptor inner segment–outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol 150:63–67PubMedCrossRef
26.
Zurück zum Zitat Otani T, Yamaguchi Y, Kishi S (2010) Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 30:774–780PubMedCrossRef Otani T, Yamaguchi Y, Kishi S (2010) Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 30:774–780PubMedCrossRef
27.
Zurück zum Zitat Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61PubMedCrossRef Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61PubMedCrossRef
28.
Zurück zum Zitat Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136PubMedCrossRef Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136PubMedCrossRef
29.
Zurück zum Zitat Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111:218–224PubMedCrossRef Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111:218–224PubMedCrossRef
30.
Zurück zum Zitat Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C (1990) The natural course of central retinal vein occlusion. Am J Ophthalmol 110:118–123PubMed Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C (1990) The natural course of central retinal vein occlusion. Am J Ophthalmol 110:118–123PubMed
31.
Zurück zum Zitat Subramanian ML, Heier JS, Esrick E, Devaiah AK, Topping TM, Frederick AR, Morley MG (2006) Preoperative visual acuity as a prognostic indication for laser treatment of macular edema due to branch retinal vein occlusion. Ophthalmic Surg Laser Imaging 37:462–467 Subramanian ML, Heier JS, Esrick E, Devaiah AK, Topping TM, Frederick AR, Morley MG (2006) Preoperative visual acuity as a prognostic indication for laser treatment of macular edema due to branch retinal vein occlusion. Ophthalmic Surg Laser Imaging 37:462–467
32.
Zurück zum Zitat Hirami Y, Mandai M, Takahashi M, Teramukai S, Tada H, Yoshimura N (2009) Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration. Jpn J Ophthalmol 53:396–407PubMedCrossRef Hirami Y, Mandai M, Takahashi M, Teramukai S, Tada H, Yoshimura N (2009) Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration. Jpn J Ophthalmol 53:396–407PubMedCrossRef
33.
Zurück zum Zitat Kwon SI, Ko SJ, Park IW (2009) The clinical course of the idiopathic epiretinal membrane after surgery. Korean J Ophthalmol 23:249–252PubMedCrossRef Kwon SI, Ko SJ, Park IW (2009) The clinical course of the idiopathic epiretinal membrane after surgery. Korean J Ophthalmol 23:249–252PubMedCrossRef
34.
Zurück zum Zitat Matsumoto H, Sato T, Kishi S (2009) Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 148:105–110PubMedCrossRef Matsumoto H, Sato T, Kishi S (2009) Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 148:105–110PubMedCrossRef
35.
Zurück zum Zitat Marshall J, Hamilton AM, Bird AC (1975) Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol 59:610–630PubMedCrossRef Marshall J, Hamilton AM, Bird AC (1975) Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol 59:610–630PubMedCrossRef
36.
Zurück zum Zitat Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW (2002) Verteporfin photodynamic terapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Invest Ophthalmol Vis Sci 43:2384–2391PubMed Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW (2002) Verteporfin photodynamic terapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Invest Ophthalmol Vis Sci 43:2384–2391PubMed
37.
Zurück zum Zitat Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106:1915–1923PubMedCrossRef Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106:1915–1923PubMedCrossRef
38.
Zurück zum Zitat Wakabayashi T, Fujiwara M, Sakaguchi H, Kusaka S, Oshima Y (2010) Foveal microstructural and visual acuity in surgically closed macular hole: spectral domain optical coherence tomographic analysis. Ophthalmology 117:1815–1824PubMedCrossRef Wakabayashi T, Fujiwara M, Sakaguchi H, Kusaka S, Oshima Y (2010) Foveal microstructural and visual acuity in surgically closed macular hole: spectral domain optical coherence tomographic analysis. Ophthalmology 117:1815–1824PubMedCrossRef
39.
Zurück zum Zitat Wolf-Schnurrbusch UE, Ghanem R, Rothenbuehler SP, Enzmann V, Framme C, Wolf S (2011) Predictors of short term outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci 52(6):3334–3337PubMedCrossRef Wolf-Schnurrbusch UE, Ghanem R, Rothenbuehler SP, Enzmann V, Framme C, Wolf S (2011) Predictors of short term outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci 52(6):3334–3337PubMedCrossRef
40.
Zurück zum Zitat Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A (2003) Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135:169–177PubMedCrossRef Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A (2003) Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135:169–177PubMedCrossRef
41.
Zurück zum Zitat Deak GG, Bolz M, Ritter M, Prager S, Benesch T, Schmidt-Erfurth U, Diabetic Retinopathy Research Group Vienna (2010) A systematic correlation between morphology and functional alterations in diabetic macular edema. Invest Ophthalmol Vis Sci 51:6710–6714PubMedCrossRef Deak GG, Bolz M, Ritter M, Prager S, Benesch T, Schmidt-Erfurth U, Diabetic Retinopathy Research Group Vienna (2010) A systematic correlation between morphology and functional alterations in diabetic macular edema. Invest Ophthalmol Vis Sci 51:6710–6714PubMedCrossRef
42.
Zurück zum Zitat Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20:126–133PubMedCrossRef Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20:126–133PubMedCrossRef
43.
Zurück zum Zitat Kaiser P, Riemann C, Sears J, Lewis H (2001) Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 131:44–49PubMedCrossRef Kaiser P, Riemann C, Sears J, Lewis H (2001) Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 131:44–49PubMedCrossRef
44.
Zurück zum Zitat Han IC, Jaffe GJ (2010) Evaluation of artifacts associated with macular spectral-domain optical coherence Tomography. Ophthalmology 117:1177–1189PubMedCrossRef Han IC, Jaffe GJ (2010) Evaluation of artifacts associated with macular spectral-domain optical coherence Tomography. Ophthalmology 117:1177–1189PubMedCrossRef
45.
Zurück zum Zitat Dale EA, Hood DC, Greenstein VC, Odel JG (2010) A comparison of multifocal ERG and frequency domain OCT changes in patients with abnormalities of the retina. Doc Ophthalmol 120:175–186PubMedCrossRef Dale EA, Hood DC, Greenstein VC, Odel JG (2010) A comparison of multifocal ERG and frequency domain OCT changes in patients with abnormalities of the retina. Doc Ophthalmol 120:175–186PubMedCrossRef
Metadaten
Titel
Association between photoreceptor integrity and visual outcome in diabetic macular edema
verfasst von
Hyun Jin Shin
Seung Hyen Lee
Hyewon Chung
Hyung Chan Kim
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2012
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-011-1774-x

Weitere Artikel der Ausgabe 1/2012

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2012 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.